Nurulimab (Anti-CTLA-4 / CD152)Nurulimab (Anti-CTLA-4 / CD152)
Move your mouse over image or click to enlarge

Nurulimab (Anti-CTLA-4 / CD152)

Nurulimab (Anti-CTLA-4 / CD152) is a monoclonal antibody directed against the human T-cell-expressed receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA4, CTLA-4), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 145.34 KD.
Cat# Size Price Qty Buy
A2859-1mg*25 1mg*25
£2,432.00
A2859-1mg*5 1mg*5
£794.00
A2859-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2859

Related Documents